GLI1 Inhibitor SRI-38832 Attenuates Chemotherapeutic Resistance by Downregulating NBS1 Transcription in BRAFV600E Colorectal Cancer
Resistance to radiation and chemotherapy in colorectal cancer (CRC) patients contribute significantly to refractory disease and disease progression. Herein, we provide mechanistic rationale for acquired or inherent chemotherapeutic resistance to the anti-tumor effects of 5-fluorouracil (5-FU) that i...
Main Authors: | Ruowen Zhang, Jinlu Ma, Justin T. Avery, Vijaya Sambandam, Theresa H. Nguyen, Bo Xu, Mark J. Suto, Rebecca J. Boohaker |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.00241/full |
Similar Items
-
GLI1: A Therapeutic Target for Cancer
by: Justin T. Avery, et al.
Published: (2021-05-01) -
Targeting the Sonic Hedgehog Signaling Pathway: Review of Smoothened and GLI Inhibitors
by: Tadas K. Rimkus, et al.
Published: (2016-02-01) -
Hedgehog Signaling and Truncated GLI1 in Cancer
by: Daniel Doheny, et al.
Published: (2020-09-01) -
Activation of Cilia-Independent Hedgehog/GLI1 Signaling as a Novel Concept for Neuroblastoma Therapy
by: Anke Koeniger, et al.
Published: (2021-04-01) -
β-arrestin1-mediated acetylation of Gli1 regulates Hedgehog/Gli signaling and modulates self-renewal of SHH medulloblastoma cancer stem cells
by: Evelina Miele, et al.
Published: (2017-07-01)